No profile data available.
AstraZeneca PLC (AZN) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Cambridge, United Kingdom, with about 96,100 full-time employees.
It reported revenue of $58.74 billion for fiscal year 2025, up 8.6% from fiscal year 2024, and net income of $10.23 billion. In Q2 2026 (the quarter ended June 30, 2026) revenue was $15.38 billion, up 6.4% from a year before. United States was its largest region in fiscal year 2025, with 41% of revenue. Its market capitalization was $246.90 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AstraZeneca reported $58.74 billion in revenue for fiscal year 2025, up 8.6% from $54.07 billion in fiscal year 2024. In Q2 2026 revenue was $15.38 billion.
United States: 41% of revenue by region in fiscal year 2025, followed by China (11%).
$246.90 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Johnson & Johnson (JNJ), AbbVie Inc. (ABBV), Novartis AG (NVS), Amgen Inc. (AMGN).